Sheila P Handattu

Title: Sheila P Handattu: Innovator in Synthetic Apolipoprotein Research

Introduction

Sheila P Handattu is a notable inventor based in Vestavia Hills, Alabama. She has made significant contributions to the field of synthetic peptides, particularly in relation to apolipoprotein E (ApoE). Her work focuses on developing innovative solutions to combat cholesterol-related health issues.

Latest Patents

Sheila P Handattu holds a patent for "Synthetic apolipoprotein E mimicking polypeptides and methods of use." This invention provides novel synthetic ApoE-mimicking peptides that enhance low-density lipoprotein (LDL) and very low-density lipoprotein (VLDL) binding to and degradation by fibroblast or HepG2 cells. The synthetic peptides have potential applications in lowering human plasma LDL/VLDL cholesterol levels, thereby inhibiting atherosclerosis. Additionally, her invention relates to synthetic peptides that can improve HDL function and exert anti-inflammatory properties. She has 1 patent to her name.

Career Highlights

Sheila is associated with the UAB Research Foundation, where she continues her research and development in the field of synthetic peptides. Her work is crucial in advancing the understanding of cholesterol metabolism and its implications for cardiovascular health.

Collaborations

Sheila has collaborated with esteemed colleagues such as Gattadahalli M Anantharamaiah and David W Garber. These collaborations have further enriched her research and contributed to the advancement of her innovative work.

Conclusion

Sheila P Handattu is a pioneering inventor whose work in synthetic apolipoprotein research holds promise for improving cardiovascular health. Her contributions are vital in the ongoing fight against cholesterol-related diseases.